Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
All the Right Moves: Cramer's 'Mad Money' Recap (Tuesday 1/14/20)
By Scott Rutt
Jan 14, 2020 8:38 PM EST
PRESS RELEASES
Revance To Participate In The 39th Annual J.P. Morgan Healthcare Conference
By Business Wire
Jan 7, 2021 4:05 PM EST
PRESS RELEASES
Revance Provides Corporate Update And Anticipated Milestones For 2021
By Business Wire
Jan 7, 2021 8:00 AM EST
PRESS RELEASES
Ajinomoto Bio-Pharma Services And Revance Therapeutics Announce Manufacturing Agreement For Supply Of DaxibotulinumtoxinA For Injection
By PR Newswire
Dec 22, 2020 8:00 AM EST
PRESS RELEASES
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Dec 21, 2020 4:05 PM EST
PRESS RELEASES
Nashville Skyline (Photo: Business Wire)
By Business Wire
Dec 16, 2020 8:30 AM EST
PRESS RELEASES
FDA Defers Approval Of DaxibotulinumtoxinA For Injection In Glabellar Lines Due To COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspection
By Business Wire
Nov 25, 2020 8:30 AM EST
PRESS RELEASES
Revance To Participate In The Piper Sandler 32nd Annual Virtual Healthcare Conference
By Business Wire
Nov 24, 2020 4:05 PM EST
PRESS RELEASES
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Nov 20, 2020 4:05 PM EST
PRESS RELEASES
Revance To Participate In The Stifel 2020 Virtual Healthcare Conference
By Business Wire
Nov 10, 2020 4:05 PM EST
PRESS RELEASES
Revance Announces Results Of Phase 2 Trial Of DaxibotulinumtoxinA For Injection In Plantar Fasciitis
By Business Wire
Nov 9, 2020 4:05 PM EST
PRESS RELEASES
Revance To Participate In The Credit Suisse 29th Annual Healthcare Conference
By Business Wire
Nov 3, 2020 4:05 PM EST
PRESS RELEASES
Revance To Release Third Quarter 2020 Financial Results On Monday, November 9, 2020
By Business Wire
Nov 2, 2020 4:05 PM EST
PRESS RELEASES
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Oct 23, 2020 4:05 PM EDT
PRESS RELEASES
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Sep 23, 2020 4:05 PM EDT
PRESS RELEASES
Revance To Participate In The Morgan Stanley 18th Annual Global Healthcare Conference
By Business Wire
Sep 8, 2020 4:05 PM EDT
PRESS RELEASES
Revance To Participate In The Wells Fargo Securities Healthcare Conference
By Business Wire
Sep 2, 2020 8:00 AM EDT
PRESS RELEASES
Revance Commercial Infrastructure Established And Positioned To Launch Prestige Aesthetics Portfolio With The RHA® Collection Of Dermal Fillers
By Business Wire
Aug 25, 2020 8:00 AM EDT
PRESS RELEASES
Revance Announces Two Peer-Reviewed Publications Reporting Safety And Efficacy Results From The SAKURA 3 Open-Label Safety Study In Dermatologic Surgery
By Business Wire
Aug 11, 2020 8:30 AM EDT
PRESS RELEASES
Revance To Release Second Quarter 2020 Financial Results On Thursday, August 6, 2020
By Business Wire
Jul 30, 2020 4:05 PM EDT
PRESS RELEASES
Revance Completes Previously Announced Acquisition Of HintMD And Its Proprietary Fintech Platform For Aesthetic Practices
By Business Wire
Jul 23, 2020 6:20 PM EDT
PRESS RELEASES
Revance Announces Last Patient Enrolled In Modified JUNIPER Phase 2 Upper Limb Spasticity Trial Of DaxibotulinumtoxinA For Injection
By Business Wire
Jun 30, 2020 4:05 PM EDT
PRESS RELEASES
Revance To Participate In The 40th Annual William Blair Growth Stock Conference
By Business Wire
Jun 4, 2020 4:05 PM EDT
PRESS RELEASES
Revance To Present At The Goldman Sachs 41st Annual Global Healthcare Conference Webcast
By Business Wire
Jun 2, 2020 4:05 PM EDT
PRESS RELEASES
Revance And Mylan To Advance Development Program For Biosimilar To BOTOX®
By Business Wire
Jun 1, 2020 8:30 AM EDT
